As we reflect on the year, we are grateful for the opportunities to innovate and improve patient care. We are especially thankful for the advancements in vascular medicine, which helps deliver safer, more effective treatments for complex conditions. Here’s to continued progress, health, and healing in the year ahead! #NewYear #2025 #InnovativeMedicine
Cagent Vascular
Medical Equipment Manufacturing
Wayne, PA 3,682 followers
Restoring Blood Flow. Restoring Life. Serranator: Serrate & Inflate
About us
Cagent Vascular (Wayne, PA) has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology
- Website
-
http://www.cagentvascular.com
External link for Cagent Vascular
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Wayne, PA
- Type
- Privately Held
- Founded
- 2014
Locations
-
Primary
Get directions
150 Strafford Avenue
Suite 315
Wayne, PA 19087, US
Employees at Cagent Vascular
-
Alexis Shewfelt
Medical Device Clinical Affairs Professional
-
Aaron Green
Chief Financial Officer at Cagent Vascular
-
John Zehren
Founder Green OR, CCO Cagent Vascular, Board Member Single Pass
-
Robert Giasolli
Co-Founder, Chief Technical Officer, and VP of Research and Development at Cagent Vascular LLC
Updates
-
Dr. Grilli treats a calcific anterior tibial and peroneal artery. A 2.5x120mm Serranator was used to provide excellent lumen gain and restore blood flow to the foot. No dissections were observed. #PAD #Angioplasty #VascularHealth #CriticalLimbsaving
-
-
Dr. Grilli treats the entire anterior tibial with a 3x120mm and 2.5x80mm #Serranator. Results showed brisk blood flow through the foot. #PAD #Angioplasty #VascularHealth #CriticalLimbsaving
-
-
Happy Holidays from the SerraNation to you! Stay safe, warm, and well! #MerryChristmas #Xmas #HappyHolidays
-
-
By achieving predictable luminal gain and minimizing dissection, #Serranator promotes optimal results. This purpose-built technology has proven to be an effective treatment strategy, while minimizing the need for reintervention. #VascularSurgery #InnovationInMedicine #PatientCare #Angioplasty
-
Treat the entire leg with the #Serranator and see improvement in lumen gain, increased blood flow, and reduction in recoil. Using 1000x more point force of a plain balloon, Serranator is leveling up the standard of vascular care. #VascularHealth #CriticalLimbsaving #PAD
-
-
Incredible case by Dr. Lichtenberg demonstrating the power of Serration Angioplasty. #Serranator provided excellent lumen gain without dissection or recoil prior to the use of DCB in this challenging CLTI disease.
Up to 2/3 of tibial lesions treated with balloon angioplasty develop restenosis within the first 3 to 6 months . Contemporary studies with PTA as primary treatment reveal suboptimal procedural and 1 year outcomes. Restenosis leads to worse ambulatory status, more incomplete healing and worse resolution of rest pain. Specific devices for the BTK segment are warranted, including devices for preventing recoil, treating dissections, and preventing neointimal hyperplasia with proven DCB technology to optimize durability of endovascular interventions and ultimately improve the limb-related outcomes with CLTI patients. This case of a CLTI patient shows a BTK lesion preparation strategy with the Serranator balloon followed by Acotec Litos DCB angioplasty (3.0x200mm). !No vessel wall dissection or recoil answer after scoring balloon angioplasty! "Litos DCBs strikingly reduced LLL, vessel reocclusion, and clinically driven target lesion revascularization compared with POBA in BTK angioplasty. " Liistro F et al JACC Cardiovasc Interv. 2020 Oct 12;13(19):2277-2286. doi: 10.1016/j.jcin.2020.06.045. Epub 2020 Sep 16. PMID: 32950416. We need more trials to prove a new concept of BTK revascularization, obviously ! Konstantinos Stavroulakis mariano palena Bruno Migliara Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Prof. Dr. Christos Rammos, MHBA Arne Stachmann Fabrizio Fanelli Marianne Brodmann
-
A patient presented with a toe wound and previous toe amputations. A 6x40mm #Serranator was used to treat the distal SFA and a 3.5x120mm Serranator to treat popliteal. Excellent lumen gain was observed without any dissection. #PAD #Angioplasty #VascularHealth #CriticalLimbsaving
-
-
The #Serranator’s novel serration angioplasty technology delivers predictable and controlled lumen gain using low pressure and is effective in both fibrotic and calcific lesions. Simplify your patient care journey and elevate treatment efficacy. #MedicalInnovation#Angioplasty #VascularHealth #HealthcareTechnology
-
The #Serranator treats the entire leg while offering predictable lumen gain and effectiveness in all lesion morphologies. Serration Angioplasty utilizes point force with stainless steel serrated strips and optimizes results. #VascularHealth #CriticalLimbsaving #PAD
-